Clinical Trial Market Research Reports & Industry Analysis
Filter your search
Research Assistance
Clinical Trial Industry Research & Market Reports
-
Clinical Trial Support Services in the US - Industry Market Research Report
...private sector. Meanwhile, government austerity measures hurt industry revenue as the federal government sought to reduce debt. Nonetheless, strong investment in clinical studies for oncology and medical devices, as well as increased requirements for trial ... Read More
-
Asthma Pipeline Highlights – 2017 Update
...therapies for Asthma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, ... Read More
-
Europe Migraine Market and Competitive Landscape – 2017
...forecast, product forecasts, and market shares. This study accurately estimates and forecast Migraine market size and drug sales. This research also provides insights into Migraine epidemiology and late stage pipeline. The report is classified into ... Read More
-
Global Cognitive Assessment & Training Market By Component (Solutions Vs. Services), By Assessment Type (Pen & Paper, Online & Biometric), By End User (Healthcare, Education & Others), By Region, Competition Forecast & Opportunities, 2012 – 2022
...– 2022 Global cognitive assessment & training market is projected to reach $9.48 billion by the end of 2022. Growth is expected to be driven by several factors including rising adoption of cognitive assessment & ... Read More
-
USA Insulin Pump Market & Users, CGM (Continuous Glucose Monitoring) Market & Users, Reimbursement Policy (By States), Diabetes (Type1 & 2) Population, Deal Types, Clinical Trials & Forecast
...to cross US$ 5 Billion by end of the year 2022. Insulin Pump has now become a well-known and a favored device for Type1 diabetes patients in the United States. The easiness of using insulin ... Read More
-
Amyloid Protein Blockers -Pipeline Insights, 2017
...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Amyloid Protein Blockers by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More
-
Anti GM-CSF Antibody -Pipeline Insights, 2017
...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti GM-CSF Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More
-
Anti-CD19 Antibody -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD19 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2017
...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD274 (PD-L1) Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More
-
Anti-CD3 Antibody -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD3 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Anti-CD33 Antibody -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD33 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Anti-CD38 Antibody -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD38 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Anti-CD40 Antibody -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD40 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Anti-CD52 Antibody -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD52 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Anti-CD80 Antibody -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-CD80 Antibody by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Anti-Mucin 1 (MUC1) Antibody -Pipeline Insights, 2017
...pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Anti-Mucin 1 (MUC1) Antibody by development stage, therapy type, route of administration and molecule type is also covered in ... Read More
-
Arginine Depletors -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Arginine Depletors by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Benzodiazepine Receptor Agonist -Pipeline Insights, 2017
...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Benzodiazepine Receptor Agonist by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More
-
Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) -Pipeline Insights, 2017
...complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) by development stage, therapy type, route of administration and ... Read More
-
Estrogen Receptor Beta Partial Agonist -Pipeline Insights, 2017
...of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Estrogen Receptor Beta Partial Agonist by development stage, therapy type, route of administration and molecule type is ... Read More
-
Factor IX -Pipeline Insights, 2017
...clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Factor IX by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a ... Read More
-
Fc-Gamma Receptor Antagonist -Pipeline Insights, 2017
...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Fc-Gamma Receptor Antagonist by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More
-
HIV Attachment Inhibitor -Pipeline Insights, 2017
...covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of HIV Attachment Inhibitor by development stage, therapy type, route of administration and molecule type is also covered in the report. It ... Read More
-
VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insights, 2017
...The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor by development stage, ... Read More
-
Voltage-Dependent T-Type Calcium Channel Blockers -Pipeline Insights, 2017
...of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Voltage-Dependent T-Type Calcium Channel Blockers by development stage, therapy type, route of administration and molecule type is ... Read More
